80 FR 15034 - Controlled Substances: 2015 Proposed Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 54 (March 20, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 54 (March 20, 2015)
| Page Range | 15034-15035 | |
| FR Document | 2015-06456 |
[Federal Register Volume 80, Number 54 (Friday, March 20, 2015)] [Notices] [Pages 15034-15035] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-06456] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-410] Controlled Substances: 2015 Proposed Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Notice with request for comments. ----------------------------------------------------------------------- SUMMARY: Three synthetic cannabinoids: N-(1-amino-3-methyl-1-oxobutan- 2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N- (1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA), and [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone (THJ-2201) were temporarily placed in schedule I of the Controlled Substances Act by a final order published by the Drug Enforcement Administration on January 30, 2015 (80 FR 5042). This means that any person that wishes to manufacture AB-CHMINACA, AB-PINACA, or THJ-2201 after January 30, 2015, must be registered with the Drug Enforcement Administration and have obtained a manufacturing quota pursuant to 21 CFR part 1303. The Drug Enforcement Administration cannot issue individual manufacturing quotas for AB-CHMINACA, AB-PINACA, or THJ-2201 until it establishes aggregate production quotas. Therefore, this notice proposes the 2015 aggregate production quotas for AB-CHMINACA, AB- PINACA, and THJ-2201. DATES: Interested persons may file written comments on this notice in accordance with 21 CFR 1303.11(c). Electronic comments must be submitted, and written comments must be postmarked, on or before April 20, 2015. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period. Based on comments received in response to this Notice, the Administrator may hold a public hearing on one or more issues raised. In the event the Administrator decides in her sole discretion to hold such a hearing, the Administrator will publish a notice of any such hearing in the Federal Register. After consideration of any comments and after a hearing, if one is held, the Administrator will publish in the Federal Register a final order establishing the 2015 aggregate production quotas for AB-CHMINACA, AB-PINACA, and THJ-2201. ADDRESSES: To ensure proper handling of comments, please reference ``Docket No. DEA-410'' on all correspondence, including any attachments. The Drug Enforcement Administration encourages that all comments be submitted electronically through the Federal eRulemaking Portal which provides the ability to type short comments directly into the comment field on the Web page or attach a file for lengthier comments. Please go to http://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments that duplicate an electronic submission are not necessary and are discouraged. Should you wish to mail a paper comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Imelda L. Paredes, Office of Diversion Control, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598- 6812. SUPPLEMENTARY INFORMATION: Posting of Public Comments Please note that all comments received in response to this docket are considered part of the public record and will be made available for public inspection online at http://www.regulations.gov. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase ``PERSONAL IDENTIFYING INFORMATION'' in the first paragraph of your comment. You must also place all the personal identifying information you do not want publicly available in the first paragraph of your comment and identify what information you want redacted. If you want to submit confidential business information as part of your comment, but do not want it to be made publicly available, you must include the phrase ``CONFIDENTIAL BUSINESS INFORMATION'' in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be posted online or made available in the public docket. Comments containing personal identifying information or confidential [[Page 15035]] business information identified as directed above will be made publicly available in redacted form. An electronic copy of this document is available at http://www.regulations.gov for easy reference. If you wish to personally inspect the comments and materials received, these materials will be available for public inspection by appointment. To arrange a viewing, please see the For Further Information Contact paragraph above. Legal Authority and Background Section 306 of the Controlled Substances Act (CSA), 21 U.S.C. 826, requires that the Attorney General establish aggregate production quotas for each basic class of controlled substance listed in schedules I and II each year. This responsibility has been delegated to the Administrator of the Drug Enforcement Administration (DEA). 28 CFR 0.100. The DEA established the 2015 aggregate production quotas for substances in schedules I and II on September 8, 2014 (79 FR 53216). Subsequently, on December 19, 2014, DEA published in the Federal Register a notice of intent to temporarily place 3 synthetic cannabinoids: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA), N-(1-amino- 3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB- PINACA), and [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- yl)methanone (THJ-2201) into schedule I of the CSA (79 FR 75767). On January 30, 2015, the DEA published in the Federal Register a final order to temporarily place these three synthetic cannabinoids in schedule I of the CSA (80 FR 5042), making all regulatory controls pertaining to schedule I controlled substances applicable to the manufacture of these three synthetic cannabinoids, including the requirement to establish an aggregate production quota pursuant to 21 U.S.C. 826 and 21 CFR part 1303. AB-CHMINACA, AB-PINACA, and THJ-2201 were non-controlled substances when the aggregate production quotas for schedule I and II substances were established. Therefore no aggregate production quotas for AB- CHMINACA, AB-PINACA, and THJ-2201 were established at that time. In determining the 2015 aggregate production quotas of these three synthetic cannabinoids, the Administrator considered the following factors in accordance with 21 U.S.C. 826(a) and 21 CFR 1303.11(b): (1) Total net disposal of the class by all manufacturers during the current and 2 preceding years; (2) trends in the national rate of net disposal of the class; (3) total estimated inventories of the basic class and of all substances manufactured from the class, and trends in inventory accumulation; (4) projected demand for each class as indicated by procurement quotas requested pursuant to 21 CFR 1303.12; and (5) other factors affecting medical, scientific, research, and industrial needs of the United States and lawful export requirements, as the Administrator finds relevant. These quotas do not include imports of controlled substances for use in industrial processes. The Administrator, therefore, proposes that the annual 2015 aggregate production quotas for the following temporarily controlled schedule I controlled substances, expressed in grams of anhydrous acid or base, be established as follows: ------------------------------------------------------------------------ Proposed 2015 Basic class--schedule I quota (g) ------------------------------------------------------------------------ N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- 15 (cyclohexylmethyl)-1H-indazole-3-carboxamide (AB- CHMINACA).............................................. N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H- 15 indazole-3-carboxamide (AB-PINACA)..................... [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1- 15 yl)methanone (THJ-2201)................................ ------------------------------------------------------------------------ Dated: March 12, 2015. Michele M. Leonhart, Administrator. [FR Doc. 2015-06456 Filed 3-19-15; 8:45 am] BILLING CODE 4410-09-P
methanone (THJ-2201) were received a Comment Tracking Number,
should be addressed to the Assistant temporarily placed in schedule I of the your comment has been successfully
Attorney General, Environment and Controlled Substances Act by a final submitted and there is no need to
Natural Resources Division, and should order published by the Drug resubmit the same comment. Paper
refer to United States and the State of Enforcement Administration on January comments that duplicate an electronic
Indiana v. Exide Technologies, D.J. Ref. 30, 2015 (80 FR 5042). This means that submission are not necessary and are
No. 90–5–2–1–11003. All comments any person that wishes to manufacture discouraged. Should you wish to mail a
must be submitted no later than thirty AB-CHMINACA, AB-PINACA, or THJ- paper comment in lieu of an electronic
(30) days after the publication date of 2201 after January 30, 2015, must be comment, it should be sent via regular
this notice. Comments may be registered with the Drug Enforcement or express mail to: Drug Enforcement
submitted either by email or by mail: Administration and have obtained a Administration, Attention: DEA Federal
manufacturing quota pursuant to 21 Register Representative/ODXL, 8701
To submit CFR part 1303. Morrissette Drive, Springfield, Virginia
Send them to:
comments: The Drug Enforcement 22152.
By email ....... pubcomment-ees.enrd@
Administration cannot issue individual FOR FURTHER INFORMATION CONTACT:
usdoj.gov. manufacturing quotas for AB- Imelda L. Paredes, Office of Diversion
By mail ......... Assistant Attorney General CHMINACA, AB-PINACA, or THJ-2201 Control, Drug Enforcement
U.S. DOJ—ENRD until it establishes aggregate production Administration; Mailing Address: 8701
P.O. Box 7611 quotas. Therefore, this notice proposes Morrissette Drive, Springfield, Virginia
Washington, D.C. 20044– the 2015 aggregate production quotas for
7611.
22152; Telephone: (202) 598–6812.
AB-CHMINACA, AB-PINACA, and THJ-
SUPPLEMENTARY INFORMATION:
2201.
During the public comment period, Posting of Public Comments
DATES: Interested persons may file
the Consent Decree may be examined
written comments on this notice in Please note that all comments
and downloaded at this Justice
accordance with 21 CFR 1303.11(c). received in response to this docket are
Department Web site: http://
Electronic comments must be considered part of the public record and
www.usdoj.gov/enrd/Consent_
submitted, and written comments must will be made available for public
Decrees.html. We will provide a paper
be postmarked, on or before April 20, inspection online at http://
copy of the Consent Decree upon
2015. Commenters should be aware that www.regulations.gov. Such information
written request and payment of
the electronic Federal Docket includes personal identifying
reproduction costs (at 25 cents per
Management System will not accept information (such as your name,
page). Please mail your request and a
comments after 11:59 p.m. Eastern Time address, etc.) voluntarily submitted by
check or money order payable to the
on the last day of the comment period. the commenter.
United States Treasury to: Consent Based on comments received in
Decree Library, U.S. DOJ—ENRD, P.O. The Freedom of Information Act
response to this Notice, the applies to all comments received. If you
Box 7611, Washington, DC 20044–7611. Administrator may hold a public
The cost for a paper copy of the want to submit personal identifying
hearing on one or more issues raised. In information (such as your name,
Consent Decree is $8.25.
the event the Administrator decides in address, etc.) as part of your comment,
Randall M. Stone, her sole discretion to hold such a but do not want it to be posted online
Acting Assistant Section Chief, hearing, the Administrator will publish or made available in the public docket,
Environmental Enforcement Section, a notice of any such hearing in the you must include the phrase
Environment and Natural Resources Division. Federal Register. After consideration of ‘‘PERSONAL IDENTIFYING
[FR Doc. 2015–06369 Filed 3–19–15; 8:45 am] any comments and after a hearing, if one INFORMATION’’ in the first paragraph
BILLING CODE 4410–15–P is held, the Administrator will publish of your comment. You must also place
in the Federal Register a final order all the personal identifying information
establishing the 2015 aggregate you do not want publicly available in
DEPARTMENT OF JUSTICE production quotas for AB-CHMINACA, the first paragraph of your comment and
AB-PINACA, and THJ-2201. identify what information you want
Drug Enforcement Administration
ADDRESSES: To ensure proper handling redacted.
[Docket No. DEA–410] of comments, please reference ‘‘Docket If you want to submit confidential
No. DEA–410’’ on all correspondence, business information as part of your
Controlled Substances: 2015 Proposed including any attachments. The Drug comment, but do not want it to be made
Aggregate Production Quotas for Enforcement Administration encourages publicly available, you must include the
Three Temporarily Controlled that all comments be submitted phrase ‘‘CONFIDENTIAL BUSINESS
Synthetic Cannabinoids electronically through the Federal INFORMATION’’ in the first paragraph
AGENCY: Drug Enforcement eRulemaking Portal which provides the of your comment. You must also
Administration, Department of Justice. ability to type short comments directly prominently identify confidential
ACTION: Notice with request for into the comment field on the Web page business information to be redacted
mstockstill on DSK4VPTVN1PROD with NOTICES
comments. or attach a file for lengthier comments. within the comment. If a comment has
Please go to http://www.regulations.gov so much confidential business
SUMMARY: Three synthetic cannabinoids: and follow the online instructions at information that it cannot be effectively
N-(1-amino-3-methyl-1-oxobutan-2-yl)- that site for submitting comments. Upon redacted, all or part of that comment
1-(cyclohexylmethyl)-1H-indazole-3- completion of your submission you will may not be posted online or made
carboxamide (AB-CHMINACA), N-(1- receive a Comment Tracking Number for available in the public docket.
amino-3-methyl-1-oxobutan-2-yl)-1- your comment. Please be aware that Comments containing personal
pentyl-1H-indazole-3-carboxamide (AB- submitted comments are not identifying information or confidential
VerDate Sep<11>2014 20:14 Mar 19, 2015 Jkt 235001 PO 00000 Frm 00130 Fmt 4703 Sfmt 4703 E:\FR\FM\20MRN1.SGM 20MRN1](https://thefederalregister.org/doc/80_FR_15088/page/1.svg)
methanone (THJ-2201) into schedule preceding years; (2) trends in the
inspection by appointment. To arrange I of the CSA (79 FR 75767). On January national rate of net disposal of the class;
a viewing, please see the FOR FURTHER 30, 2015, the DEA published in the (3) total estimated inventories of the
INFORMATION CONTACT paragraph above. Federal Register a final order to basic class and of all substances
temporarily place these three synthetic manufactured from the class, and trends
Legal Authority and Background in inventory accumulation; (4) projected
cannabinoids in schedule I of the CSA
Section 306 of the Controlled (80 FR 5042), making all regulatory demand for each class as indicated by
Substances Act (CSA), 21 U.S.C. 826, controls pertaining to schedule I procurement quotas requested pursuant
requires that the Attorney General to 21 CFR 1303.12; and (5) other factors
controlled substances applicable to the
establish aggregate production quotas affecting medical, scientific, research,
manufacture of these three synthetic
for each basic class of controlled and industrial needs of the United
cannabinoids, including the
substance listed in schedules I and II States and lawful export requirements,
requirement to establish an aggregate
each year. This responsibility has been as the Administrator finds relevant.
production quota pursuant to 21 U.S.C.
delegated to the Administrator of the These quotas do not include imports of
Drug Enforcement Administration 826 and 21 CFR part 1303.
controlled substances for use in
(DEA). 28 CFR 0.100. AB-CHMINACA, AB-PINACA, and industrial processes.
The DEA established the 2015 THJ-2201 were non-controlled The Administrator, therefore,
aggregate production quotas for substances when the aggregate proposes that the annual 2015 aggregate
substances in schedules I and II on production quotas for schedule I and II production quotas for the following
September 8, 2014 (79 FR 53216). substances were established. Therefore temporarily controlled schedule I
Subsequently, on December 19, 2014, no aggregate production quotas for AB- controlled substances, expressed in
DEA published in the Federal Register CHMINACA, AB-PINACA, and THJ- grams of anhydrous acid or base, be
a notice of intent to temporarily place 3 2201 were established at that time. established as follows:
Proposed
Basic class—schedule I 2015 quota
(g)
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) .................................... 15
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) .............................................................. 15
[1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) ...................................................................................... 15
Dated: March 12, 2015. Institute for Environmental Conflict NUCLEAR REGULATORY
Michele M. Leonhart, Resolution, and Udall Center for Studies COMMISSION
Administrator. in Public Policy/Native Nations Institute
[FR Doc. 2015–06456 Filed 3–19–15; 8:45 am] for Leadership, Management, and [NRC–2015–0001]
BILLING CODE 4410–09–P Policy/Udall Archives, and resolutions
related to the Operating Procedures of Sunshine Act Meetings
the Board of Trustees and the Parks in
MORRIS K. UDALL AND STEWART L. Focus Fund, Inc. (6) Financial and DATES: March 23, 30, April 6, 13, 20, 27,
UDALL FOUNDATION Internal Controls Update; (7) Ethics 2015.
Briefing; (8) Program Panel &
PLACE:Commissioners’ Conference
Sunshine Act Meetings Discussion; and (9) Appropriations
Room, 11555 Rockville Pike, Rockville,
Update. Maryland.
TIME AND DATE: 9:00 a.m. to 4:00 p.m.,
Thursday, April 16, 2015. CONTACT PERSON FOR MORE INFORMATION:
STATUS: Public and Closed.
Philip J. Lemanski, Executive Director,
PLACE: The offices of the Morris K.
130 South Scott Avenue, Tucson, AZ Week of March 23, 2015—Tentative
Udall and Stewart L. Udall Foundation,
130 South Scott Avenue, Tucson, AZ 85701, (520) 901–8500.
Thursday, March 26, 2015
85701. Dated: March 16, 2015.
STATUS: This meeting of the Board of Philip J. Lemanski, 9:30 a.m. Briefing on Security Issues
Trustees will be open to the public. (Closed—Ex. 1)
mstockstill on DSK4VPTVN1PROD with NOTICES
Executive Director, Morris K. Udall and
MATTERS TO BE CONSIDERED: (1) Chair’s Stewart L. Udall Foundation, and Federal 1:30 p.m. Briefing on Security Issues
Remarks; (2) Executive Director’s Register Liaison Officer. (Closed—Ex. 1)
Remarks; (3) Overview of Trustee [FR Doc. 2015–06556 Filed 3–18–15; 4:15 pm]
Friday, March 27, 2015
Responsibilities; (4) Board Officers & BILLING CODE 6820–FN–P
Committee Elections; (5) Consent 9:30 a.m. Briefing on Threat
Agenda Approval, including program Environment Assessment (Closed—
reports of the Education Programs, U.S. Ex. 1)
VerDate Sep<11>2014 20:14 Mar 19, 2015 Jkt 235001 PO 00000 Frm 00131 Fmt 4703 Sfmt 4703 E:\FR\FM\20MRN1.SGM 20MRN1](https://thefederalregister.org/doc/80_FR_15088/page/2.svg)
Document Created: 2015-12-18 11:34:50
Document Modified: 2015-12-18 11:34:50
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice with request for comments. | |
| Dates | Interested persons may file written comments on this notice in accordance with 21 CFR 1303.11(c). Electronic comments must be submitted, and written comments must be postmarked, on or before April 20, 2015. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period. | |
| Contact | Imelda L. Paredes, Office of Diversion | |
| FR Citation | 80 FR 15034 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR